1. Home
  2. MERC vs CTSO Comparison

MERC vs CTSO Comparison

Compare MERC & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mercer International Inc.

MERC

Mercer International Inc.

HOLD

Current Price

$0.35

Market Cap

25.9M

ML Signal

HOLD

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$5.46

Market Cap

23.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MERC
CTSO
Founded
1968
1997
Country
Canada
United States
Employees
N/A
N/A
Industry
Paper
Medical/Dental Instruments
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.9M
23.9M
IPO Year
2005
2008

Fundamental Metrics

Financial Performance
Metric
MERC
CTSO
Price
$0.35
$5.46
Analyst Decision
Hold
Buy
Analyst Count
3
2
Target Price
$2.25
$5.38
AVG Volume (30 Days)
3.4M
349.4K
Earning Date
05-07-2026
05-01-2026
Dividend Yield
7.01%
N/A
EPS Growth
N/A
65.79
EPS
N/A
N/A
Revenue
$1,169,145,000.00
$22,503,908.00
Revenue This Year
$13.75
$10.34
Revenue Next Year
$10.12
$22.41
P/E Ratio
N/A
N/A
Revenue Growth
25.50
48.53
52 Week Low
$0.34
$0.30
52 Week High
$2.96
$7.44

Technical Indicators

Market Signals
Indicator
MERC
CTSO
Relative Strength Index (RSI) 33.84 77.40
Support Level $0.35 $0.48
Resistance Level $0.65 $7.44
Average True Range (ATR) 0.02 0.42
MACD 0.01 0.20
Stochastic Oscillator 28.78 74.12

Price Performance

Historical Comparison
MERC
CTSO

About MERC Mercer International Inc.

Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The company has a geographical presence in the USA, Germany, China, and Other countries, where the maximum of revenue is generated from the China. The majority of the revenue is generated from the Pulp segment.

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

Share on Social Networks: